Azelby Robert Insider Trades

Insider Trading History

Track insider trading activity for Azelby Robert. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $0 0 shares
Last Trade
May 05, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.86M 91,697 shares
$52.97
$52.95
Autolus Therapeutics plc
Autolus Therapeutics plc AUTL
Director
Holding Value $0 0 shares
Last Trade
Mar 18, 2026 Sale
$580k 400,000 shares
$1.45
$1.66
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $89.9k 1,697 shares
Last Trade
Feb 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.7k 1,697 shares
$34.60
$52.95
Cardinal Health
Cardinal Health CAH
Director
Holding Value $935k 4,085 shares
Last Trade
Nov 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210k 1,067 shares
$196.84
$228.91
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $92.5k 80,405 shares
Last Trade
Jun 13, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$45.1k 12,600 shares
$3.58
$1.15
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $107k 93,005 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 40,000 shares
$3.59
$1.15
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $4.77M 90,000 shares
Last Trade
Feb 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$372k 90,000 shares
$4.13
$52.95
Cardinal Health
Cardinal Health CAH
Director
Holding Value $691k 3,018 shares
Last Trade
Nov 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 1,730 shares
$115.58
$228.91
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $61k 53,005 shares
Last Trade
Jun 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.2k 6,995 shares
$2.89
$1.15
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $69k 60,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$126k 40,000 shares
$3.16
$1.15
Cardinal Health
Cardinal Health CAH
Director
Holding Value $295k 1,288 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 1,288 shares
$110.61
$228.91
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Director
Holding Value $23k 20,000 shares
Last Trade
Jan 02, 2024 Sale
$52.4k 31,000 shares
$1.69
$1.15
Chinook Therapeutics
Chinook Therapeutics KDNY
Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.42M 35,200 shares
$40.39
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Director
Holding Value $1.14M 28,200 shares
Last Trade
Apr 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$760k 35,200 shares
$21.60
$40.39
Eliem Therapeutics
Eliem Therapeutics ELYM
President & CEO
Holding Value $2.56M 500,000 shares
Last Trade
Oct 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.64M 500,000 shares
$3.27
$5.11
Eliem Therapeutics
Eliem Therapeutics ELYM
President & CEO
Holding Value $2.56M 500,000 shares
Last Trade
Jan 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.11M 500,000 shares
$8.21
$5.11
Eliem Therapeutics
Eliem Therapeutics ELYM
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Aug 09, 2021 Sale
No data
No data
$5.11
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $3.43k 42,223 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$252k 42,223 shares
$5.97
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $3.26k 40,138 shares
Last Trade
Jun 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$260k 40,138 shares
$6.48
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $2.35k 28,882 shares
Last Trade
Jun 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$423k 28,882 shares
$14.66
$0.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up